Mouse Bleomycin Hydrolase (BLMH) Protein (Active)

Product Graph
975€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Mouse Bleomycin Hydrolase (BLMH) Protein (Active)
category
Proteins and Peptides
provider
Abbexa
reference
abx693308
tested applications
SDS-PAGE

Description

Mouse BLMH Protein is a recombinant protein from Mouse produced in E. coli. A DNA sequence encoding the mouse BLMH (NP_848760.1) (Asn 2-Glu 455) was expressed, with a polyhistide tag at the N-terminus.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
BLMH
Host
E. coli
Assay Type
Activity: Active
Sequence Fragment: Asn2-Glu455
Tag: N-terminal His tag
Origin
Mouse
Observed MW
53.3 kDa
Expression
Recombinant
Purity
> 95% (SDS-PAGE)
Size 1
50 µg
Form
Lyophilized
Tested Applications
SDS-PAGE
Buffer
Lyophilized from sterile 50mM Tris, 0.15M NaCl, 10% glycerol, pH 8.0.
Availability
Shipped within 5-15 working days.
Storage
Storage: Store lyophilized between -20 °C and -80°C.
Stability: Stable when stored reconstituted at 2-8°C for up to 1 week. Reconstituted aliquots are stable at -20°C for up to 3 months.
Shelf Life: 12 months.
Dry Ice
No
NCBI Accession
NP_848760.1
Background
Protein BLMH
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Descripción

Related Products

FNab00907

BLMH antibody

Bleomycin hydrolase (BMH) is a cytoplasmic cysteine peptidase that is highly conserved through evolution; however, the only known activity of the enzyme is metabolic inactivation of the glycopeptide bleomycin (BLM), an essential component of combination chemotherapy regimens for cancer. The protein contains the signature active site residues of the cysteine protease papain superfamily.

Ver Producto
P5760

Recombinant Human BLMH

Ver Producto
abx034944

Bleomycin Hydrolase (BLMH) Antibody

The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B-aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity (By similarity).

Ver Producto